Literature DB >> 810481

Altered crystal violet permeability and lytic behavior in antibiotic-resistant and -sensitive mutants of Neisseria gonorrhoeae.

L F Guymon, P F Sparling.   

Abstract

Wild-type, antibiotic-resistant and hypersensitive isogenic strains of Neisseria gonorrhoeae were studied for uptake of crystal violet, rates of autolysis, and response to lysozyme. Total uptake of crystal violet was similar in all strains at 0 C but varied significantly at 37 C. Mutation at the nonspecific resistance locus ery resulted in relative impermeability to crystal violet at 37 C, as compared to wild type. The penetration barrier to crystal violet at 37 C was overcome by addition of 5 mM ethylenediaminetetraacetic acid. Mutation at ery also resulted in reduced rates of autolysis and reduced sensitivity to high concentrations of lysozyme under conditions of divalent cation (Mg2+) depletion. In contrast, mutation at the nonspecific drug hypersensitivity locus env resulted in increased uptake of crystal violet at 37 C, due to increased binding of dye to crude envelope as well as increased penetration into cytoplasm. The env mutants were also more rapidly autolytic and more sensitive to lysozyme than wild type in the absence of Mg2+. These results suggest that the cell envelopes of ery mutants are more stable and less permeable and those of env mutants are less stable and more permeable than wild-type strains.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 810481      PMCID: PMC235965          DOI: 10.1128/jb.124.2.757-763.1975

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  31 in total

1.  A NONSPECIFIC INCREASE IN PERMEABILITY IN ESCHERICHIA COLI PRODUCED BY EDTA.

Authors:  L LEIVE
Journal:  Proc Natl Acad Sci U S A       Date:  1965-04       Impact factor: 11.205

2.  [Electron microscopic study on plasmas containing desoxyribonucleic acid. I. Nucleoids of actively growing bacteria].

Authors:  A RYTER; E KELLENBERGER; A BIRCHANDERSEN; O MAALOE
Journal:  Z Naturforsch B       Date:  1958-09       Impact factor: 1.047

3.  Isolation and characterization of an Escherichia coli mutant with alteration in the outer membrane porteins of the cell envelope.

Authors:  H C Wu
Journal:  Biochim Biophys Acta       Date:  1972-12-01

4.  Genetics and physiology of colicin-tolerant mutants of Escherichia coli.

Authors:  R Nagel de Zwaig; S E Luria
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

Review 5.  The barrier function of the gram-negative envelope.

Authors:  L Leive
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

6.  Discussion paper: antibiotic-sensitive mutants of Escherichia coli possess altered outer membranes.

Authors:  H L Ennis; M I Bloomstein
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

7.  [Investigations on the effect of crystal violet on salmonella R mutants. 1. Communication: binding experiments (author's transl)].

Authors:  S Alexanian; S Schlecht; O Westphal
Journal:  Zentralbl Bakteriol Orig A       Date:  1974-02

8.  Regulation of the bacterial cell wall: isolation and characterization of peptidoglycan mutants of Staphylococcus aureus.

Authors:  A N Chatterjee; F E Young
Journal:  J Bacteriol       Date:  1972-07       Impact factor: 3.490

9.  Lipopolysaccharide and aldoheptose biosynthesis in transketolase mutants of Salmonella typhimurium.

Authors:  L Eidels; M J Osborn
Journal:  Proc Natl Acad Sci U S A       Date:  1971-08       Impact factor: 11.205

10.  Relationship between permeability, cell division, and murein metabolism in a mutant of Escherichia coli.

Authors:  C Lazdunski; B M Shaprio
Journal:  J Bacteriol       Date:  1972-08       Impact factor: 3.490

View more
  32 in total

1.  Penetrability of the outer membrane of Neisseria gonorrhoeae in relation to acquired resistance to penicillin and other antibiotics.

Authors:  R A Scudamore; T J Beveridge; M Goldner
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

2.  Cell envelope alterations in antibiotic-sensitive and-resistant strains of Neisseria gonorrhoeae.

Authors:  L F Guymon; D L Walstad; P F Sparling
Journal:  J Bacteriol       Date:  1978-10       Impact factor: 3.490

3.  FarR regulates the farAB-encoded efflux pump of Neisseria gonorrhoeae via an MtrR regulatory mechanism.

Authors:  E-H Lee; C Rouquette-Loughlin; J P Folster; W M Shafer
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

Review 4.  Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  Stephanie Schielke; Matthias Frosch; Oliver Kurzai
Journal:  Med Microbiol Immunol       Date:  2010-04-09       Impact factor: 3.402

5.  A doctor's dilemma: choices amidst change.

Authors:  P Frederick Sparling
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

6.  Regulation of mtrF expression in Neisseria gonorrhoeae and its role in high-level antimicrobial resistance.

Authors:  Jason P Folster; William M Shafer
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

7.  The MtrR repressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae.

Authors:  C E Lucas; J T Balthazar; K E Hagman; W M Shafer
Journal:  J Bacteriol       Date:  1997-07       Impact factor: 3.490

8.  Towards an understanding of chromosomally mediated penicillin resistance in Neisseria gonorrhoeae: evidence for a porin-efflux pump collaboration.

Authors:  William M Shafer; Jason P Folster
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

9.  Antibiotic resistance in Neisseria denitrificans.

Authors:  C R MacKenzie; I J McDonald; K G Johnson
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

10.  Multiple antibiotic resistance in clinical strains of Neisseria gonorrhoeae isolated in South Carolina.

Authors:  J T Powell; J H Bond
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.